The
According to reports, the team and the player are in the process of gathering additional medical opinions to determine the most effective treatment path. The Eagles have maintained that the health of their quarterback is the primary priority, and they intend to defer to the guidance of his medical team regarding his eventual return to the field. While the possibility of an injured reserve designation remains open should future medical evaluations necessitate it, the current focus is on managing the condition with the best available care.
Medical Outlook and Roster Adjustments
The treatment of blood clots typically involves the use of anticoagulants, or blood thinners, which prevent players from participating in contact sports. While medical experts unaffiliated with the team suggest that a standard recovery timeline for such cases could span approximately six weeks, there remains a possibility for shorter recovery windows depending on the severity and location of the clot. The Eagles noted that the clot had moved, a factor that often influences the necessity of blood-thinning medication.
In the absence of their starter, the Eagles are adjusting their roster to maintain depth.
This development adds to a challenging period for the Philadelphia organization, which is already managing injuries to key offensive contributors. Running back Saquon Barkley, who is expected to return next week, has been ruled out for the Sunday matchup against Carolina. These personnel hurdles follow a tumultuous stretch for the team, which has recently navigated the retirement of offensive tackle Lane Johnson and the trade of center Cam Jurgens.
